Articles by Association for Diagnostics and Laboratory Medicine

Not only will the elimination of CLIAC have a negative impact on patient care, it also isn’t likely to result in meaningful savings for the government

ADLM congressional briefing explains the importance of laboratory developed tests for pediatric care and the FDA rule that will limit access to these critical tests

Sabrina Reilly has been named chief membership and market development officer for ADLM, effective December 10

In a statement, ADLM president Octavia Peck Palmer strongly supports Rep. Cassidy’s letter to the FDA asking how the agency plans to change its current practices under the recent Supreme Court ruling

ADLM president urging the FDA to involve all stakeholders in modernizing LDT regulation to improve patient care